RT Journal Article
SR Electronic
T1 Early Detection Of COVID-19 Using A Smartwatch
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.06.20147512
DO 10.1101/2020.07.06.20147512
A1 Mishra, Tejaswini
A1 Wang, Meng
A1 Metwally, Ahmed A.
A1 Bogu, Gireesh K
A1 Brooks, Andrew W
A1 Bahmani, Amir
A1 Alavi, Arash
A1 Celli, Alessandra
A1 Higgs, Emily
A1 Dagan-Rosenfeld, Orit
A1 Fay, Bethany
A1 Kirkpatrick, Susan
A1 Kellogg, Ryan
A1 Gibson, Michelle
A1 Wang, Tao
A1 Rolnik, Benjamin
A1 Ganz, Ariel B
A1 Li, Xiao
A1 Snyder, Michael P
YR 2020
UL http://medrxiv.org/content/early/2020/07/07/2020.07.06.20147512.abstract
AB Wearable devices digitally measuring vital signs have been used for monitoring health and illness onset and have high potential for real-time monitoring and disease detection. As such they are potentially useful during public health crises, such as the current COVID-19 global pandemic. Using smartwatch data from 31 infected individuals identified from a cohort of over 5000 participants, we investigated the use of wearables for early, presymptomatic detection of COVID-19. From physiological and activity data, we first demonstrate that COVID-19 infections are associated with alterations in heart rate, steps and sleep in 80% of COVID-19 infection cases. Failure to detect these changes in the remaining patients often occurred in those with chronic respiratory/lung disease. Importantly the physiological alterations were detected prior to, or at, symptom onset in over 85% of the positive cases (21/24), in some cases nine or more days before symptoms. Through daily surveys we can track physiological changes with symptom onset and severity. Finally, we develop a method to detect onset of COVID-19 infection in real-time which detects 67% of infection cases at or before symptom onset. Our study provides a roadmap to a rapid and universal diagnostic method for the large-scale detection of respiratory viral infections in advance of symptoms, highlighting a useful approach for managing epidemics using digital tracking and health monitoring.Competing Interest StatementMPS is cofounder and a member of the scientific advisory board of Personalis, Qbio, January, SensOmics, Protos, Mirvie, Oralome. He is on the scientific advisory board of Danaher, Genapsys, and Jupiter. This work was supported by gifts from the Flu Lab. Diana Berrent from Survivor Corps provided assistance in recruitment. Amy McDonough and Taylor Helgren from Fitbit Inc. provided assistance in accessing Fitbit data. Fitbit Inc. promoted this study and donated Fitbit devices. The Stanford Healthcare Innovation Lab gratefully acknowledges the support of Alexandra Duisberg. Google Cloud Platform (GCP) costs were covered by Google for Education Academic Research and COVID-19 grant awards.Funding StatementThis work was supported by NIH grants, and gifts from the Flu Lab, and departmental funding from the Stanford Genetics department. We thank Diana Berrent from Survivor Corps for assistance in recruitment as well as Amy McDonough and Taylor Helgren from Fitbit Inc. for help in accessing Fitbit data. We thank Fitbit for promoting this study and for the donation of devices. The Stanford Healthcare Innovation Lab gratefully acknowledges the support of Alexandra Duisberg. Google Cloud Platform (GCP) costs were covered by Google for Education Academic Research and COVID-19 grant awards. This work was also supported by the Start-up/Departmental Funding and the HPC award for COVID-19 Research, which were both received by XL from Case Western Reserve University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We recruited 5,262 adult individuals for this study under protocol 55577 approved by the Stanford University Institutional Review Board. Participants were recruited using REDCap and informed electronic consent was obtained from all participants. Recruitment was done through social media, word of mouth, COVID-19 registries, presentations, as well as from Stanford HealthCare.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified raw heart rate, steps, and sleep data used in this study can be downloaded from: https://storage.googleapis.com/gbsc-gcp-project-ipop_public/COVID-19/COVID-19-Wearables.zipData used for analyses and participant metadata is provided in supplemental tables.https://storage.googleapis.com/gbsc-gcp-project-ipop_public/COVID-19/COVID-19-Wearables.zip